Utility of a High-Throughput Electrophysiology Assay to Determine Pathogenicity of SCN5A Variants Associated With Brugada Syndrome - 30/07/23
Doi : 10.1016/j.hlc.2023.06.763
G. Ma 1, 2, M. O’Neill 3, E. Richardson 4, 5, K. Thomson 6, 7, J. Ingles 4, 5, D. Roden 3, J. Vandenberg 1, 2, C. Ng 1, 2, A. Glazer 3
1 Victor Chang Cardiac Research Institute, Sydney, NSW, Australia
2 University of New South Wales, Sydney, NSW, Australia
3 Vanderbilt University Medical Center, Nashville, TN, USA
4 Centre for Population Genomics, Murdoch Children's Research Institute, Melbourne, Vic, Australia
5 Centre for Population Genomics, Garvan Institute of Medical Research and UNSW Sydney, Sydney, NSW, Australia
6 Radcliffe Department of Medicine, University of Oxford, Division of Cardiovascular Medicine, John Radcliffe Hospital, Oxford, United Kingdom
7 Oxford Medical Genetics Laboratories, Churchill Hospital, Oxford, United Kingdom
041
Le texte complet de cet article est disponible en PDF.Plan
© 2023
Publié par Elsevier Masson SAS.
Vol 32 - N° S3
P. S131-S132 - juillet 2023 Retour au numéro
Article précédent
- Overexpression of Mitochondrial Catalase in Adipose Tissue Improves Survival and Cardiac Cachexia in AOM-DSS Model of Colitis-associated Colorectal Cancer
- A. Croft, C. Kelly, D. Chen, L. Murtha, S. Sugito, T. Haw, A. Boyle, A. Sverdlov, D. Ngo
- Baseline Transvalvular Gradient Predicts Reduction in Pressure Augmentation Index Following Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis
- N. Song, M. Namasivayam, C. Hayward, D. Muller, A. Adji
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?